PerkinElmer Stock Soars While Molecular Devices Falls

After announcing its third-quarter results last week, PerkinElmer watched its stock jump 17 percent while Molecular Devices fell 13 percent for the five-day period ending Tuesday as the BioCommerce Week Index ended three consecutive weeks of losses.

Twelve of the 15 companies closed the week with their stock prices up over last week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.